Clinical Trials Directory

Trials / Completed

CompletedNCT00462722

Myogenic and Osteogenic Responses to eXercise and Ibuprofen

COX Inhibition & Musculoskeletal Responses to Exercise

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
159 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
60 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if the use of ibuprofen blocks the benefits of exercise to build bone and muscle mass.

Detailed description

People are advised to engage in weight-bearing physical activity to help prevent the loss of bone and muscle mass that occurs with aging. There is evidence from studies of animals that non-steroidal anti-inflammatory drugs (NSAIDS), such as ibuprofen, block some of the bone- and muscle-building effects of exercise. The aim of this study is to determine whether use of ibuprofen, either before or after exercise, blocks the benefits of exercise training on bone and skeletal muscle in older women and men. The hypothesis is that taking ibuprofen before exercise will block some of the effects of exercise training to increase bone density and muscle mass. Women and men aged 60-75 years will complete a supervised, 9-month exercise training program designed to increase bone and muscle mass. The training will include weight lifting and weight-bearing exercises, such as jumping in place and treadmill walking, up to 5 days per week. Participants will be randomly assigned to take 1 of 3 study pill combinations before and after each exercise session. The combinations of study pills will be: placebo before/placebo after, placebo before/ibuprofen after, or ibuprofen before/placebo after. The dose of ibuprofen will be 400 mg. Bone density of the hip and spine, body composition (total body muscle and fat), and markers of bone turnover in the blood will be measured before and after 4.5 and 9 months of training. Muscle cross-sectional area of the thigh will be measured by CT before and after 9 months of training. A subset of participants will have biopsies of the thigh muscle before and after training to measure proteins and genes associated with muscle build-up and breakdown. Volunteers who do not use ibuprofen, aspirin, or acetaminophen more than 3 days per month will be enrolled. People with intolerance to ibuprofen or related drugs, cardiovascular disease, or orthopedic problems that limit exercise will be excluded from the study.

Conditions

Interventions

TypeNameDescription
DRUGIbuprofen400 mg with each exercise session (up to 5 days per week) for 9 months
DRUGPlacebowith each exercise session (up to 5 days per week) for 9 months
BEHAVIORALmusculoskeletal-loading exerciseExercise training program designed to increase bone and muscle mass, including weight lifting and weight-bearing exercises such as jumping in place and treadmill walking up to 5 days per week for 9 months

Timeline

Start date
2007-07-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2007-04-19
Last updated
2015-11-02
Results posted
2015-08-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00462722. Inclusion in this directory is not an endorsement.